SCHEMBL19804471

SCHEMBL19804471

C=C(C)C(=O)OCc1cc(-c2ccc(-c3ccccc3)cc2F)ccc1OCCO

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 3/20 0.43
ALOX5AP P20292 2/20 0.43
SLC6A9 P48067 5/20 0.40
RARA P10276 2/20 0.39
RARB P10826 2/20 0.39
RARG P13631 2/20 0.39
PRKAB2 O43741 2/20 0.39
PRKAG1 P54619 2/20 0.39
PRKAA2 P54646 2/20 0.39
PRKAA1 Q13131 2/20 0.39
PRKAG3 Q9UGI9 2/20 0.39
PRKAG2 Q9UGJ0 2/20 0.39
PRKAB1 Q9Y478 2/20 0.39
PPARD Q03181 2/20 0.38
PGR P06401 1/20 0.36
PTGS1 P23219 1/20 0.36
PDE4A P27815 1/20 0.36
ESR1 P03372 1/20 0.36
EGFR P00533 1/20 0.36
DHODH Q02127 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19804738 1.00 FEN1 (0.43) FEN1ALOX5APSLC6A9RARARARB
SCHEMBL19804398 0.91 ALOX5AP (0.42) FEN1ALOX5APSLC6A9RARARARB
SCHEMBL19804500 0.91 SLC6A9 (0.45) SLC6A9RARARARBRARGESR1
SCHEMBL19804366 0.90 RARB (0.45) SLC6A9RARARARBRARGESR1
SCHEMBL19804354 0.89 ALOX5AP (0.41) FEN1ALOX5APSLC6A9RARARARB
SCHEMBL19804068 0.89 ALOX5AP (0.41) FEN1ALOX5APSLC6A9RARARARB
SCHEMBL19804326 0.89 SLC6A9 (0.40) SLC6A9RARARARBRARGPPARD
SCHEMBL19804554 0.88 FEN1 (0.41) FEN1ALOX5APRARARARBRARG
SCHEMBL19803964 0.88 CTSA (0.38) FEN1ALOX5APRARARARBRARG
SCHEMBL19804476 0.88 RARB (0.41) SLC6A9RARARARBRARGESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 FEN1 2669/4885ALOX5AP 2507/4885SLC6A9 2938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.